Effect of VEGF, P53 and telomerase on angiogenesis of gastric carcinoma tissue  by Yu, Yan-Fang et al.
293Asian Pacific Journal of Tropical Medicine (2014)293-296
Document heading          doi: 10.1016/S1995-7645(14)60041-9 
Effect of VEGF, P53 and telomerase on angiogenesis of gastric 
carcinoma tissue
Yan-Fang Yu*, Yong Zhang, Na Shen, Rui-Ying Zhang, Xin-Qing Lu*
Affiliated Hospital of Hebei University of Engineering, Handan 056002, Hebei, China
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 10 December 2013
Received in revised form 15 January 2014
Accepted 15 February 2014
Available online 20 April 2014
Keywords:
VEGF
P53
Telomerase
Angiogenesis
Gastric carcinoma
  *Corresponding author: Yan-Tang Yu, M.M., Affiliated Hospital of Hebei University 
of Engineering, Handan 056002, Hebei, China.
     Tel: 13513106510
     E-mail: yyfangtg@163.com 
    Xin-Qing Lu, Ph.D., Chief Physician, Affiliated Hospital of Hebei University of 
Engineering, Handan 056002, Hebei, China.
    Foundation project: It is supported by Handan City Technology Bureau Scientific 
Research Project (No 1023108101-8).
1. Introduction
  Gastric cancer is a common malignant digestive system 
disease, with serious damages to patients’ health. Cancer 
cells transformation genes phenotypic change are closely 
related to angiogenesis. The growth and metastasis depends 
on the formation of new blood vessels, and tumor vascular 
endothelial growth factor (VEGF) plays a key role in the 
formation of new blood vessels[1-3]. P53 is an important 
tumor suppressor genes. It inhibits the growth of the 
transformed cells, and the cells in vivo tumorigenicity, 
which affect cell proliferation and prevent the happening of 
the carcinoma[4]. Studies have shown that[5], wild-type P53 
can inhibit VEGF expression, tumor growth and metastasis. 
Mutant P53 can increase the expression of VEGF, promote 
tumor angiogenesis, growth and metastasis. Telomerase can 
regulate cell growth, prevent chromosomal integration end 
to end, restructuring and degradation, and thus can stabilize 
chromosome, ensuring a complete copy of chromosomes. 
Studies have shown that[6], the occurrence/development 
of malignant tumor is closely related to telomerase, which 
can be used as an effective marker for the diagnosis of 
malignant tumor. This study examined the 95 specimens of 
gastric cancer by immunohistochemical method to detect 
the relationship between of VEGF, P53 and telomerase, and 
their effects on tumor angiogenesis of gastric carcinoma.
2. Materials and methods
2.1. Reagent and instrument
  Mouse anti human CD34 monoclonal antibody (dilution: 
1:50), rabbit anti human VEGF polyclonal antibody, rabbit 
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anti human TRT polyclonal antibody (dilution: 1:75) and rat 
P53 monoclonal antibody against human (dilution: 1:250) 
were provided by Santa Cruz co.; APES dropping pills, 
pancreatic enzyme digestive agent, second antibody, triple 
antibody, DAB chromogenic reagent kit were provided by 
the Golden Bridge Biotechnology co. LTD, China.
2.2. Specimen source
  Surgical resection specimens were collected from 
gastric carcinoma tissue of 95 cases (55 male and female 
40 cases, aged 27-78, an average of 60.23 years old) 
admitted in our hospital from January 2009 to January 2010. 
Histological type: 42 cases of tubular adenocarcinoma, 22 
cases of papillary adenocarcinoma, 16 cases of mucous 
adenocarcinoma, 5 cases of gland scale cancer, 10 cases 
of Dijon cell carcinoma. Another 30 resection specimens 
of normal gastric tissue from distal carcinoma above were 
taken for contrast tests.
2.3. Dyeing method
  Slides were soaked in acid pool for 24 h, they were rinsed 
and dried. APES was diluted with acetone 1:50 for 20-30 sec, 
APES uncombinated with pure acetone was removed, and 
boxed for later use. Gastric cancer tissue was sliced in 4 毺m
in oven at 80 ℃ for 3 h. Slice underwent conventional 
dewaxing, ethanol hydration, 3% hydrogen peroxide 
incubation for 10 min. It was rinsed with distilled water, PBS 
for 5 min, and underwent 1:50 EDTA antigen hot fix. Goat 
serum was added for incubation at room temperature for
15 min. The primary antibody was added, then they was 
washed by PBS, added with biotin secondary antibody 
drops for incubation at 37 ℃ for 15 min. They were washed 
with PBS, added with triple antibody drops, then were 
incubated at 37 ℃ for 15 min, washed by PBS. Telomerase 
dyeing methods: antigen retrieval was performed by enzyme 
digestion + hot retrieval method. Blank control was included 
in all dyeings above, with PBC instead of primary antibody.
2.3. Result judgement
  Positive telomerase staining was defined with 10% tumor 
cell cytoplasm and cell membrane with tan color. Positive 
MVC dyeing was defined with obvious tumor cells, or 
other organization components had other a brown cells 
or cell cluster as a blood vessel, as long as the structure 
was not connected to a vascular branch structure. At low 
magnification, the highest microvascular density zones 
within the tumor tissue was looked up, them it was searched 
at high magnification. capillary number of 5 highest 
vascular density zones was counted, to calculate the average 
microvascular density (MVD). Positive VEGF staining was 
defined with over 10% per biopsy in the cytoplasm or cell 
membrane stained. P53 staining with nuclei in tan color was 
defined as positive.
2.4. statistical analysis
  Data was analyzed bySPSS12.0 statistics software, measured 
data were represented with (mean依sd) using t test, P<0.05 
was considered as significant difference.
3. Results
3.1. VEGF expression results
  VEGF, P53 and telomerase positive expression in normal 
gastric mucosa tissue was not found, VEGF positive 
expression 52 cases in gastric cancer group (56.52%).VEGF 
expression was mainly in the cytoplasm, a tan granular 
staining. More strong staining was found at tumor infiltration 
front, weak VEGF staining was found around the endothelial 
cells and tumor tissues, The expression rate of gastric 
cancer group was 42.11%, P53  was expressed in nucleus, 
tinting darker than in low differentiated adenocarcinoma 
well-differentiated adenocarcinomas. Telomerase positive 
expression positive was 74.74%, the positive staining for tan 
granule was mainly in the cytoplasm and cell membrane, 
patches were distributed in tumor tissues. (Figure 1).
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Figure 1. Expression of VEGF, P53 and telomerase (×200).
Yang-Fang Yu et al./Asian Pacific Journal of Tropical Medicine (2014)293-296 295
3.2. Relationship between VEGF, P53, telomerase and MVD 
expression 
  On the basis of VEGF staining intensity, expression is 
divided into four grades, less than 10% tumor cells cytoplasm 
or membrane dyeing is identified for negative (-), 10%-20% 
for weakly positive (+), 20%-30% for positive (++), more than 
30% for strong positive (+). VEGF (-) MVD was 32.5依9.3, (+) 
average MVD was 48.7依18.4, visible MVD increases with 
VEGF expression, difference between groups was statistically 
significant (P<0.05) (Figure 2a). There was positive correlation 
between P53 positive expression and MVD. P53 (-) MVD was 
35.8依9.8, P53 (+) MVD was 46.1依16.7, which means MVD 
increases with P53 expression enhancement, difference 
between groups was statistically significant (P<0.05) (Figure 
2b). MVD was 47.81依9.2 in telomerase positive tissue, 44.76
依8.4 in the negative tissue, difference between groups was 
statistically significant (P<0.05) (Figure 2c).
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Figure 2. Relationship between VEGF, P53, telomerase and MVD 
expression.
4. Discussion 
  The occurrence and development of tumor are complex 
biological process, malignant invasive tumor growth and 
metastasis are the main cause of treatment failure[7]. Its 
growth and metastasis depends on angiogenesis, new blood 
vessels not only provide nutrition for their growth, also 
provide channels for transfer. Studies have shown that[8-
10], VEGF is widely expressed in gastric cancer cells, 
promoting angiogenesis, which is the important mechanism 
of the gastric cancer invasion and metastasis. Numerous 
studies have found that[11-13], VEGF expression is found 
in almost all malignant tumors, and not found or only low 
levels of expression in normal tissue, it also showed that 
VEGF expression is closely related to the occurrence, 
development and prognosis of gastric cancer. Other studies 
have suggested[14-17], P53 gene mutation is considered to be 
the common genetic events of all kinds of tumor and normal 
cells, wild-type P53 protein is difficult to measure by routine 
immunohistochemical method, while half-life prolong 
obviously as  the gene mutation, and protein conformation 
change, therefore, the application of immunohistochemical 
method to detect of P53 are all mutant protein. Other studies 
have shown that[18-20], telomerase is closely related to the 
occurrence and development of malignant tumor, while 
the activity of telomerase on its own in the mammalian 
development showed no direct biological effect. The cells 
survival and organs balance requires enough telomerase 
structure to maintain in the cell division, and telomerase in 
most tumors telomerase activity can be detected.
  This experiment showed that the expression of VEGF is 
associated with histological type, poorly differentiated tissue 
VEGF positive expression rate is higher; in gastric cancer 
tissues with VEGF positive expression, MVD count was 
significantly higher than that of VEGF negative (P<0.05), 
indicating that in the development process of gastric cancer, 
increased VEGF expression promotes the formation of new 
blood vessels in cancerous tissue, plays an important role 
in the process of the tumor occurrence and development. 
This group of materials, the expression of VEGF is increased 
along with the enhancement of P53 expression, it showed 
that P53 mutations can up-regulate VEGF expression 
and promote the tumor angiogenesis. This positive rate of 
telomerase expression in gastric cancer tissue was 74.74%, 
with higher MVD value in tumor tissue of telomerase (+) than 
that of (-). It indicates telomerase prompts angiogenesis by 
the way different from mutant P53, telomerase expression 
augmentation of the malignant tumors suggests an increase 
for the potential of occurrence, development and metastasiss 
its[21-23].
  This study shows that the VEGF plays an important role 
in gastric cancer occurrence and development process, 
can be used as an index of diagnosis and predicting the 
prognosis of gastric cancer, by promoting the expression of 
VEGF. P53 mutation promotes tumor angiogenesis. As a key 
event in tumor angiogenesis formation, telomerase increases 
angiogenesis in gastric cancer tissue by other pathway 
different from P53.
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